id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0525-0006,FDA,FDA-2002-E-0525,Determination of Regulatory Review Period fo Purposes of Patent Extension; GALILEO INTRAVASCULAR RADIOTHERAPY SYSTEM,Notice,N-Notice,2007-05-21T04:00:00Z,2007,5,2007-05-18T04:00:00Z,2007-07-21T03:59:59Z,2008-07-17T19:45:56Z,,0,0,09000064804a5768
FDA-2002-E-0525-0005,FDA,FDA-2002-E-0525,FDA/CDER to U.S. Patent and Trademark Office,Other,LET-Letter,2007-05-17T04:00:00Z,2007,5,,,2008-04-12T01:18:59Z,,0,0,09000064804a5767
FDA-2002-E-0525-0004,FDA,FDA-2002-E-0525,USPTO to FDA/CDER -  Letter,Other,LET-Letter,2007-04-13T04:00:00Z,2007,4,,,2008-07-17T19:40:25Z,,0,0,09000064804a5766